Keyword: Small Molecules

Strategy & Management

The Winning Formula

08.09.2016 - Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...

Markets & Companies

After Pharma’s Patent Cliff

04.04.2016 - Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...

News

Blueprint and Roche in Cancer Immunotherapy Deal

17.03.2016 - US biotechnology company Blueprint Medicines is collaborating with Swiss drugs giant Roche on the discovery, development and commercialization of up to five cancer immunotherapies...

News

AstraZeneca and Sanofi Swap Compounds

30.11.2015 - Drugs firms AstraZeneca and Sanofi are to exchange 210,000 compounds from their libraries to help boost their search for new small-molecule medicines. The companies have selected...

Plant Construction & Process Technology

Chances and Hurdles for Biosimilars

07.10.2015 - With biosimilars the pharmaceutical industry and health-care business move into a relatively young discipline with high sales potential. The follow-up drugs of biopharmaceuticals...

News

Sanofi and Lead Pharma Seal Autoimmune R&D Pact

24.02.2015 - French drugmaker Sanofi and Dutch biotech Lead Pharma have entered a research collaboration and license agreement to discover, develop and commercialize small-molecule therapies...

News

Bristol-Myers Squibb Completes Amira Acquisition

09.09.2011 - Bristol-Myers Squibb said Thursday that it has completed its acquisition of privately held Amira Pharmaceuticals, a small-molecule pharmaceutical company focused on the discovery...

News

Bristol-Myers to Acquire Amira Pharma For $325 Million

22.07.2011 - Bristol-Myers Squibb said Thursday it has agreed to acquire Amira Pharmaceuticals, a privately held company, for an upfront payment of $325 million in cash. The terms also include...